Latest Avastin Stories
What does a company do when there's anecdotal evidence that two of its drugs are equally effective in treating a leading cause of blindness in the elderly, one costing patients $60 per treatment and the other $2,000?
The UK's cost-effectiveness watchdog NICE has delivered another blow to the developers of targeted cancer therapies by recommending against the use of four new kidney cancer drugs in the UK.
By Gina Kolata and Andrew Pollack It took only an instant for 58-year-old Gailanne Reeh to go from the picture of health to death's door. By chance, her doctor noticed a lump under her arm during a routine exam. It turned out to be advanced breast cancer.
The cancer medication Avastin has been called a wonder drug, but may be less effective than U.S. regulators believed when they approved it. Made by Genentech, Avastin, or bevacizumab, was approved by the U.S.
By GINA KOLATA By Gina Kolata and Andrew Pollack The New York Times It took only an instant for Gailanne Reeh, 58, to go from the picture of health to death's door. By chance, her doctor noticed a lump under her arm during a routine exam. It turned out to be advanced breast cancer.
SAN DIEGO, July 1 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc.
Preliminary results show the combination of Xeloda plus Eloxatin, known as XELOX, to be equivalent to standard FOLFOX-4 chemotherapy treatment in terms of overall survival in first-line metastatic colorectal cancer patients.
LONDON (Reuters) - Two new targeted therapies for bowel cancer should not be used on Britain's state-run health service, the country's cost-effectiveness watchdog NICE said on Monday.
LOS ANGELES (Reuters) - A mid-stage trial suggests that a combination of cancer drugs Avastin and Tarceva can prolong survival in patients with advanced lung cancer, compared with chemotherapy alone, drug makers Genentech Inc.
ZURICH (Reuters) - Switzerland's Roche has filed for approval in the United States its Avastin cancer drug for treatment of the most widespread form of lung cancer, the drug-maker said on Wednesday.
- A gift; a largess; a gratuity; a present; a dole.